Takeda Manufacturing Austria AG (batch release authorization; manufacturing of medicinal products, primary and secondary packaging of medicinal products, batch quality control; batch quality control: "Sterility" and "Endotoxins")

The drug is used for the treatment and prevention of angioedema attacks in adults and children (from 2 years of age) with hereditary angioedema (HAE). It is also used to prevent attacks before medical, dental, or surgical procedures.

Dosage form: powder and solvent for injection solution

ATC: B06AC01